Gambaran Umum
Ondine Biomedical Inc., headquartered in Canada, operates primarily in the healthcare sector, focusing on the development of non-antibiotic therapies for a range of bacterial, viral, and fungal infections. A key innovator in photodisinfection technology, Ondine is recognized for its flagship project, Steriwave™, an antimicrobial photodynamic therapy designed to eliminate pathogens from the nasal passages, a common reservoir for infections, particularly in hospital settings. The company aims to expand the application of its photodisinfection technology across multiple medical environments to combat the rise of antibiotic-resistant superbugs. Through ongoing research and collaborations, Ondine Biomedical Inc. is at the forefront of advancing non-antibiotic antimicrobial treatments to improve patient outcomes and reduce healthcare-associated infections.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Ondine Biomedical Inc. per 2024 Dec 31 adalah 2.05 MM.
- Nilai operating income untuk Ondine Biomedical Inc. per 2024 Dec 31 adalah -19.44 MM.
- Nilai net income untuk Ondine Biomedical Inc. per 2024 Dec 31 adalah -19.10 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2024-12-31 | 2.05 | -19.44 | -19.10 |
| 2024-09-30 | 1.84 | -17.02 | -16.69 |
| 2024-06-30 | 1.63 | -14.61 | -14.27 |
| 2024-03-31 | 1.42 | -14.71 | -14.34 |
| 2023-12-31 | 1.20 | -14.80 | -14.41 |
| 2023-09-30 | 1.00 | -16.60 | -16.56 |
| 2023-06-30 | 0.80 | -18.39 | -18.70 |
| 2023-03-31 | 0.72 | -18.57 | -19.04 |
| 2022-12-31 | 0.64 | -18.76 | -19.37 |
| 2022-09-30 | 0.75 | -20.06 | -36.71 |
| 2022-06-30 | 0.86 | -21.36 | -54.05 |
| 2022-03-31 | 1.71 | -19.44 | -52.07 |
| 2021-12-31 | 2.57 | -17.52 | -50.09 |
| 2020-12-31 | 1.79 | -15.87 | -16.27 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | -0.06 | -0.06 |
| 2024-03-31 | -0.07 | -0.07 |
| 2023-12-31 | -0.07 | -0.07 |
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | -0.10 | -0.10 |
| 2022-12-31 | -0.10 | |
| 2022-09-30 | -0.22 | -0.22 |
| 2022-06-30 | -0.38 | -0.38 |
| 2022-03-31 | -0.47 | -0.47 |
| 2021-12-31 | -0.63 | |
| 2020-12-31 | -0.23 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Ondine Biomedical Inc. per 2024 Dec 31 adalah -15.49 MM.
- Nilai cash from investing activities untuk Ondine Biomedical Inc. per 2024 Dec 31 adalah -0.01 MM.
- Nilai kas dari aktivitas pendanaan untuk Ondine Biomedical Inc. per 2024 Dec 31 adalah 21.74 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2024-12-31 | -15.49 | -0.01 | 21.74 |
| 2024-09-30 | -14.03 | -0.01 | 15.51 |
| 2024-06-30 | -12.56 | -0.01 | 9.28 |
| 2024-03-31 | -13.11 | -0.10 | 6.53 |
| 2023-12-31 | -13.65 | -0.18 | 3.79 |
| 2023-09-30 | -14.89 | -0.20 | 1.73 |
| 2023-06-30 | -16.12 | -0.22 | -0.33 |
| 2023-03-31 | -16.23 | -0.26 | -0.30 |
| 2022-12-31 | -16.34 | -0.31 | -0.28 |
| 2022-09-30 | -17.68 | -0.30 | 19.75 |
| 2022-06-30 | -19.01 | -0.28 | 39.77 |
| 2022-03-31 | -15.78 | -0.18 | 40.83 |
| 2021-12-31 | -12.54 | -0.08 | 41.90 |
| 2020-12-31 | -6.26 | -0.10 | 6.75 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2020-12-31 |
Efektivitas Manajemen
- roa untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -2.49.
- roe untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -6.85.
- roic untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -38.58.
- croic untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -8.69.
- ocroic untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -33.95.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2024-12-31 | -2.49 | -6.85 | -38.58 | -8.69 | -33.95 |
| 2024-09-30 | -2.49 | -6.85 | -38.58 | -8.69 | -33.95 |
| 2024-06-30 | -3.46 | ||||
| 2024-03-31 | -0.87 | -1.24 | -5.49 | -3.86 | -5.20 |
| 2023-12-31 | -1.42 | -6.31 | -5.04 | ||
| 2023-09-30 | -0.86 | -3.84 | -3.35 | ||
| 2023-06-30 | -0.86 | ||||
| 2023-03-31 | -0.87 | -3.91 | -3.38 | ||
| 2022-12-31 | -1.08 | -1.24 | -2.93 | 0.15 | -1.41 |
| 2022-09-30 | -1.08 | -1.24 | -2.93 | 0.15 | -1.41 |
| 2022-06-30 | -20.51 | -2.40 | 0.90 | -0.84 | |
| 2022-03-31 | -19.76 | -2.26 | 1.08 | -0.69 | |
| 2021-12-31 | -19.01 | -1.65 | 0.96 | -0.41 | |
| 2020-12-31 | -13.30 | 0.26 | -5.12 |
Gross Margins
- marjin kotor untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah 0.60.
- marjin bersih untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -8.74.
- marjin operasi untuk Ondine Biomedical Inc. pada 2024 Dec 31 adalah -8.94.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2024-12-31 | 0.60 | -8.74 | -8.94 |
| 2024-09-30 | 0.60 | -8.74 | -8.94 |
| 2024-06-30 | |||
| 2024-03-31 | 0.58 | -11.98 | -12.31 |
| 2023-12-31 | |||
| 2023-09-30 | -23.26 | -22.87 | |
| 2023-06-30 | -23.26 | -22.87 | |
| 2023-03-31 | -26.40 | -25.76 | |
| 2022-12-31 | 0.46 | -49.15 | -26.86 |
| 2022-09-30 | 0.46 | -49.15 | -26.86 |
| 2022-06-30 | 0.46 | -63.15 | -24.95 |
| 2022-03-31 | 0.48 | -30.41 | -11.35 |
| 2021-12-31 | 0.49 | -19.50 | -6.82 |
| 2020-12-31 | 0.36 | -9.08 | -8.86 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
